Comparative in vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 12, 2000, Pages 3447-3450

  Snydman, D R ^a   Jacobus, N V ^a   McDermott, L A ^a   Lonks, J R ^a   Boyce, J M ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DAPTOMYCIN; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; ENTEROCOCCUS FAECIUM; IN VITRO STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

COLONY COUNT, MICROBIAL; DAPTOMYCIN; GRAM-POSITIVE BACTERIA; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; TIME FACTORS; VANCOMYCIN;

EID: 0034426093     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.12.3447-3450.2000     Document Type: Article

References (16)

1. Comparative in vitro activity of LY146032, a new peptide, with vancomycin and eight other agents against gram-positive organisms
2. In vitro and in vivo activity of LY146032, a new cyclic lipopeptide antibiotic
3. Rapid method for epidemiological evaluation of gram-positive cocci by field inversion gel electrophoresis
4. 2+ and albumin on these drugs
5. Fluorescence indicates a calcium-dependent interaction between the lipopeptide antibiotic LY 146032 and phospholipid membranes
6. In vitro pharmacodynamic effects of concentration, pH and growth phase on serum bactericidal activities of daptomycin and vancomycin
7. Teicoplanin and daptomycin bactericidal activities in the presence of albumin or serum under controlled conditions of pH and ionized calcium
8. Activities of daptomycin and teicoplanin against Staphylococcus haemolyticus and Staphylococcus epidermidis, including evaluation of susceptibility testing recommendations
9. Bactericidal activities of peptide antibiotics against multidrug-resistant E. faecium
10. Activity of mersacidin, a novel peptide, compared with that of vancomycin, teicoplanin, and daptomycin
11. In vitro activities of daptomycin, vancomycin, linezolid, and quinupristin-dalfopristin against staphylococci and enterococci, including vancomycin-intermediate and -resistant strains
12. Comparative in vitro activities of teicoplanin, daptomycin, ramoplanin, vancomycin, and PD127,391 against blood isolates of gram-positive cocci
13. In vitro activity of LY146032 against gram-positive bacteria